A quarter of smokers quit within a year or two of menthol bans, researchers find

The research highlights the effectiveness of menthol cigarette bans in promoting smoking cessation, based on studies conducted across various regions, including over 170 US localities, two states, several countries, and the European Union. Despite delays in implementing such bans by the Biden administration, approximately a quarter of menthol smokers quit within a year or two following the bans, emphasizing the urgent need for action from the US Food and Drug Administration (FDA) due to the clear health benefits associated with these measures.

Advocates are urging the FDA to prioritize the ban on menthol cigarettes, particularly citing the disproportionate impact of menthol cigarette marketing on marginalized communities, such as communities of color and LGBTQ+ individuals. These groups, historically targeted by the tobacco industry, experience higher rates of menthol cigarette use and related health disparities. By implementing menthol cigarette bans, public health efforts could significantly reduce smoking rates among these populations and improve overall health outcomes.

Furthermore, menthol cigarette bans not only encourage quitting among current smokers but also act as a preventive measure to deter new smokers, especially youth attracted to the appealing flavor of menthol cigarettes. This preventive aspect of the bans could contribute to long-term reductions in smoking rates and related health issues. Overall, the evidence supports the urgent need for FDA action to implement nationwide menthol cigarette bans, which could have significant public health benefits for both current and future generations.